Inhibitor of indoleamine-2,3-dioxygenase (IDO)
US10980807B2 · kind B2 · utility
2Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2017 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Feb 8, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compounds of Formula (I). The compounds described herein may be useful in treating a disease associated with IDO, for example, cancer or an infectious disease (e.g., viral or bacterial infectious diseases). Also, provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.